GlobeNewswire Inc | Oct 27, 2021 08:00AM EDT

October 27, 2021

NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc.(Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its third quarter 2021 financial results prior to market open on Wednesday, November 3, 2021. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results.

The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (855) 232-3919 (toll-free domestic) or (315) 625-6894 (international) passcode 6266006. Archived webcasts will be available on Intercepts website for approximately two weeks.

About InterceptIntercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 inNew York, Intercept has operations inthe United States,EuropeandCanada. For more information, please visitwww.interceptpharma.comor connect with the company onTwitterandLinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries:investors@interceptpharma.com

Media inquiries:media@interceptpharma.com